Carisma Therapeutics Inc. (CARM)

Import this data to Google Sheets with:

=jivedata("CARM","financials")

Full statements spill as a table. For one cell: =jivedata("CARM","Revenue") or =jivedata("CARM","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.

Carisma Therapeutics Inc.

CARM • CIK 0001485003

(in thousands, except per share data)	FY 2022	FY 2023	FY 2024	TTM
Revenue from Collaborative Arrangement, Excluding Revenue from Contract with Customer	—	$14,919	$19,632	$52,632
Operating Income (Loss)	$-25,909	$-88,731	$-62,179	$10,847
Embedded Derivative, Gain (Loss) on Embedded Derivative, Net	—	$-84	$0	$0
Interest Income (Expense), Nonoperating, Net	—	$1,936	$1,702	$1,238
Net Income (Loss) Attributable to Parent	$-19,884	$-86,879	$-60,477	$8,042
Research and Development Expense	$38,594	$74,125	$59,673	$27,355
General and Administrative Expense	$39,787	$29,525	$22,138	$14,430
Operating Expenses	$65,909	$103,650	$81,811	$41,785
Weighted Average Number of Shares Outstanding, Basic	200,546,000	33,524,197	41,456,210	41,881,212
Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Parent	—	$440	$0	$0
Reclassification from AOCI, Current Period, Net of Tax, Attributable to Parent	—	$399	$0	$0
Comprehensive Income (Loss), Net of Tax, Attributable to Parent	$-20,430	$-86,838	$-60,477	$-60,477

(in thousands, except per share data)	FY 2022	FY 2023	FY 2024	TTM
Cash and Cash Equivalents, at Carrying Value	$112,553	$77,605	$17,909	$2,777
Prepaid Expense and Other Assets, Current	$400	$2,866	$5,916	$3,090
Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization	—	$6,764	$4,385	$0
Assets, Current	$189,144	$80,471	$23,825	$5,870
Operating Lease, Right-of-Use Asset	$0	$2,173	$2,040	$684
Assets	$189,174	$89,554	$30,458	$6,554
Deferred Revenue, Noncurrent	—	$45,000	$41,250	$0
Operating Lease, Liability, Noncurrent	—	$860	$724	$609
Finance Lease, Liability, Noncurrent	—	$328	$20	$0
Other Liabilities, Noncurrent	—	$926	$318	$0
Liabilities	$30,984	$63,022	$58,367	$7,421
Accounts Payable, Current	$1,233	$3,933	$2,081	$5,571
Accrued Liabilities, Current	$29,636	$7,662	$7,448	$1,088
Deferred Revenue, Current	—	$1,413	$3,729	$0
Operating Lease, Liability, Current	$0	$1,391	$832	$153
Finance Lease, Liability, Current	—	$544	$905	$0
Other Liabilities, Current	$115	$965	$1,060	$0
Liabilities, Current	$30,984	$15,908	$16,055	$6,812
Preferred Stock, Value, Issued	$0	$0	$0	$0
Common Stock, Value, Issued	$202	$40	$41	$41
Additional Paid in Capital	$494,675	$271,594	$277,629	$278,994
Retained Earnings (Accumulated Deficit)	$-336,141	$-245,102	$-305,579	$-279,902
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	—	$26,532	$-27,909	$-867
Preferred Stock, Shares Authorized	5,000,000	5,000,000	5,000,000	5,000,000
Preferred Stock, Shares Issued	0	0	0	0
Common Stock, Shares Authorized	400,000,000	350,000,000	350,000,000	350,000,000
Common Stock, Shares, Issued	202,759,043	40,609,915	41,750,109	41,788,096

(in thousands, except per share data)	FY 2022	FY 2023	FY 2024	TTM
Net Income (Loss) Attributable to Parent	$-19,884	$-86,879	$-60,477	$8,042
Net Cash Provided by (Used in) Operating Activities	$24,895	$-81,177	$-59,917	$-22,415
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect	—	$53,411	$-59,696	$-24,104
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$133,583	$77,605	$17,909	$-30,866
Depreciation, Depletion and Amortization, Nonproduction	$13	$2,837	$3,354	$1,330
Payments to Acquire Marketable Securities	—	$34,460	$0	$0
Gain (Loss) on Disposition of Property Plant Equipment	—	$-159	$0	$187
Share-based Payment Arrangement, Noncash Expense	$6,909	$2,316	$3,649	$2,212
Payments to Acquire Property, Plant, and Equipment	—	$1,132	$123	$0
Operating Lease, Right-of-Use Asset, Amortization Expense	—	$5,428	$4,963	$658
Net Cash Provided by (Used in) Investing Activities	$-53,969	$72,408	$-123	$687
Amortization of Debt Discount (Premium)	—	$1,283	$0	$0
Embedded Derivative, Gain (Loss) on Embedded Derivative, Net	—	$-84	$0	$0
Marketable Securities, Realized Gain (Loss), Excluding Other-than-temporary Impairment Loss	—	$399	$0	$0
Sale and Leaseback Transaction, Gain (Loss), Net	—	—	$82	$0
Finance Lease, Principal Payments	—	$1,301	$1,429	$515
Payments of Financing Costs	—	$146	$0	$0
Proceeds from Stock Options Exercised	$1	$187	$4	$5
Proceeds from Issuance of Common Stock	$0	$597	$2,392	$-23
Net Cash Provided by (Used in) Financing Activities	$1	$62,180	$344	$-2,376
Interest Paid, Excluding Capitalized Interest, Operating Activities	—	$352	$192	$96
Notes Reduction	—	$42,447	$0	$0
Right-of-Use Asset Obtained in Exchange for Finance Lease Liability	—	$0	$1,660	$0
Right-of-Use Asset Obtained in Exchange for Operating Lease Liability	$0	$2,779	$6,411	$1,528
Increase (Decrease) in Prepaid Expense and Other Assets	$-18,076	$-1,046	$3,120	$-3,863
Increase (Decrease) in Accounts Payable	$-1,620	$2,191	$-1,852	$3,467
Increase (Decrease) in Accrued Liabilities	$17,067	$-2,899	$-213	$-3,453
Increase (Decrease) in Deferred Revenue	$-1,500	$-1,046	$-1,434	$-41,932
IncreaseDecreaseInOperatingLeaseLiability	—	$-4,941	$-5,525	$-1,332
Increase (Decrease) in Other Noncurrent Liabilities	—	$213	$192	$96

Loading financial statements…

Import this data to Google Sheets with:

=jivedata("CARM","financials")

Full statements spill as a table. For one cell: =jivedata("CARM","Revenue") or =jivedata("CARM","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.